4//SEC Filing
Hankey Bret 4
Accession 0001493152-19-011867
CIK 0001419554other
Filed
Aug 7, 8:00 PM ET
Accepted
Aug 8, 1:47 PM ET
Size
6.4 KB
Accession
0001493152-19-011867
Insider Transaction Report
Form 4
Hankey Bret
Director
Transactions
- Purchase
Common Stock
2019-08-06+553,191→ 27,829,860 total(indirect: By LLC)
Footnotes (3)
- [F1]Consists of shares held by Hankey Capital LLC ("Hankey Capital") as collateral for the repayment of convertible notes (the "Notes") issued to Hankey Capital (the "Collateral Shares"). Hankey Capital may not transfer, sell or otherwise dispose of any of the Collateral Shares, except during the existence of Event of Default under the Notes in connection with the exercise of its rights and remedies as a secured lender.
- [F2]Hankey Capital is owned by Hankey Investment Company LP ("HIC") of which the Bret Hankey Trust (the "Bret Trust") owns a 5.83% interest, the Rufus and Bret Hankey Trust (the "RB Trust") owns a 0.94% interest and the Hankey Children's Trust (the "Children's Trust") owns a 0.99% interest. Mr. Hankey is the settlor and trustee of the Bret Trust and Mr. Hankey's immediate family are beneficiaries of the Bret Trust; Mr. Hankey is one of the settlors of the RB Trust, of which, the Bret Trust is one of the beneficiaries and Mr. Hankey is a successor trustee of the Children's Trust. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his or his immediate family's pecuniary interest.
- [F3]Consists of shares held by Hankey Capital. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his or his immediate family's pecuniary interest.
Documents
Issuer
Bone Biologics Corp
CIK 0001419554
Entity typeother
Related Parties
1- filerCIK 0001747562
Filing Metadata
- Form type
- 4
- Filed
- Aug 7, 8:00 PM ET
- Accepted
- Aug 8, 1:47 PM ET
- Size
- 6.4 KB